809 related articles for article (PubMed ID: 25307056)
1. Human intracellular ISG15 prevents interferon-α/β over-amplification and auto-inflammation.
Zhang X; Bogunovic D; Payelle-Brogard B; Francois-Newton V; Speer SD; Yuan C; Volpi S; Li Z; Sanal O; Mansouri D; Tezcan I; Rice GI; Chen C; Mansouri N; Mahdaviani SA; Itan Y; Boisson B; Okada S; Zeng L; Wang X; Jiang H; Liu W; Han T; Liu D; Ma T; Wang B; Liu M; Liu JY; Wang QK; Yalnizoglu D; Radoshevich L; Uzé G; Gros P; Rozenberg F; Zhang SY; Jouanguy E; Bustamante J; García-Sastre A; Abel L; Lebon P; Notarangelo LD; Crow YJ; Boisson-Dupuis S; Casanova JL; Pellegrini S
Nature; 2015 Jan; 517(7532):89-93. PubMed ID: 25307056
[TBL] [Abstract][Full Text] [Related]
2. ISG15 deficiency and increased viral resistance in humans but not mice.
Speer SD; Li Z; Buta S; Payelle-Brogard B; Qian L; Vigant F; Rubino E; Gardner TJ; Wedeking T; Hermann M; Duehr J; Sanal O; Tezcan I; Mansouri N; Tabarsi P; Mansouri D; Francois-Newton V; Daussy CF; Rodriguez MR; Lenschow DJ; Freiberg AN; Tortorella D; Piehler J; Lee B; García-Sastre A; Pellegrini S; Bogunovic D
Nat Commun; 2016 May; 7():11496. PubMed ID: 27193971
[TBL] [Abstract][Full Text] [Related]
3. Modification of BECN1 by ISG15 plays a crucial role in autophagy regulation by type I IFN/interferon.
Xu D; Zhang T; Xiao J; Zhu K; Wei R; Wu Z; Meng H; Li Y; Yuan J
Autophagy; 2015 Apr; 11(4):617-28. PubMed ID: 25906440
[TBL] [Abstract][Full Text] [Related]
4. Mycobacterial disease and impaired IFN-γ immunity in humans with inherited ISG15 deficiency.
Bogunovic D; Byun M; Durfee LA; Abhyankar A; Sanal O; Mansouri D; Salem S; Radovanovic I; Grant AV; Adimi P; Mansouri N; Okada S; Bryant VL; Kong XF; Kreins A; Velez MM; Boisson B; Khalilzadeh S; Ozcelik U; Darazam IA; Schoggins JW; Rice CM; Al-Muhsen S; Behr M; Vogt G; Puel A; Bustamante J; Gros P; Huibregtse JM; Abel L; Boisson-Dupuis S; Casanova JL
Science; 2012 Sep; 337(6102):1684-8. PubMed ID: 22859821
[TBL] [Abstract][Full Text] [Related]
5. ISG15 Deficiency Enhances HIV-1 Infection by Accumulating Misfolded p53.
Osei Kuffour E; König R; Häussinger D; Schulz WA; Münk C
mBio; 2019 Aug; 10(4):. PubMed ID: 31455647
[TBL] [Abstract][Full Text] [Related]
6. The ISG15/USP18 ubiquitin-like pathway (ISGylation system) in hepatitis C virus infection and resistance to interferon therapy.
Chen L; Li S; McGilvray I
Int J Biochem Cell Biol; 2011 Oct; 43(10):1427-31. PubMed ID: 21704181
[TBL] [Abstract][Full Text] [Related]
7. A partial form of inherited human USP18 deficiency underlies infection and inflammation.
Martin-Fernandez M; Buta S; Le Voyer T; Li Z; Dynesen LT; Vuillier F; Franklin L; Ailal F; Muglia Amancio A; Malle L; Gruber C; Benhsaien I; Altman J; Taft J; Deswarte C; Roynard M; Nieto-Patlan A; Moriya K; Rosain J; Boddaert N; Bousfiha A; Crow YJ; Jankovic D; Sher A; Casanova JL; Pellegrini S; Bustamante J; Bogunovic D
J Exp Med; 2022 Apr; 219(4):. PubMed ID: 35258551
[TBL] [Abstract][Full Text] [Related]
8. Protein interferon-stimulated gene 15 conjugation delays but does not overcome coronavirus proliferation in a model of fulminant hepatitis.
Ma XZ; Bartczak A; Zhang J; He W; Shalev I; Smil D; Chen L; Phillips J; Feld JJ; Selzner N; Levy G; McGilvray I
J Virol; 2014 Jun; 88(11):6195-204. PubMed ID: 24648452
[TBL] [Abstract][Full Text] [Related]
9. Direct Antiviral Activity of IFN-Stimulated Genes Is Responsible for Resistance to Paramyxoviruses in ISG15-Deficient Cells.
Holthaus D; Vasou A; Bamford CGG; Andrejeva J; Paulus C; Randall RE; McLauchlan J; Hughes DJ
J Immunol; 2020 Jul; 205(1):261-271. PubMed ID: 32423918
[TBL] [Abstract][Full Text] [Related]
10. Systemic Type I IFN Inflammation in Human ISG15 Deficiency Leads to Necrotizing Skin Lesions.
Martin-Fernandez M; Bravo García-Morato M; Gruber C; Murias Loza S; Malik MNH; Alsohime F; Alakeel A; Valdez R; Buta S; Buda G; Marti MA; Larralde M; Boisson B; Feito Rodriguez M; Qiu X; Chrabieh M; Al Ayed M; Al Muhsen S; Desai JV; Ferre EMN; Rosenzweig SD; Amador-Borrero B; Bravo-Gallego LY; Olmer R; Merkert S; Bret M; Sood AK; Al-Rabiaah A; Temsah MH; Halwani R; Hernandez M; Pessler F; Casanova JL; Bustamante J; Lionakis MS; Bogunovic D
Cell Rep; 2020 May; 31(6):107633. PubMed ID: 32402279
[TBL] [Abstract][Full Text] [Related]
11. Evidence for an involvement of the ubiquitin-like modifier ISG15 in MHC class I antigen presentation.
Held T; Basler M; Knobeloch KP; Groettrup M
Eur J Immunol; 2021 Jan; 51(1):138-150. PubMed ID: 32686110
[TBL] [Abstract][Full Text] [Related]
12. Contribution of increased ISG15, ISGylation and deregulated type I IFN signaling in Usp18 mutant mice during the course of bacterial infections.
Dauphinee SM; Richer E; Eva MM; McIntosh F; Paquet M; Dangoor D; Burkart C; Zhang DE; Gruenheid S; Gros P; Behr M; Malo D
Genes Immun; 2014; 15(5):282-92. PubMed ID: 24807690
[TBL] [Abstract][Full Text] [Related]
13. Ube1L and protein ISGylation are not essential for alpha/beta interferon signaling.
Kim KI; Yan M; Malakhova O; Luo JK; Shen MF; Zou W; de la Torre JC; Zhang DE
Mol Cell Biol; 2006 Jan; 26(2):472-9. PubMed ID: 16382139
[TBL] [Abstract][Full Text] [Related]
14. Impairment of the DeISGylation Activity of Foot-and-Mouth Disease Virus Lpro Causes Attenuation
Medina GN; Azzinaro P; Ramirez-Medina E; Gutkoska J; Fang Y; Diaz-San Segundo F; de Los Santos T
J Virol; 2020 Jun; 94(13):. PubMed ID: 32295921
[TBL] [Abstract][Full Text] [Related]
15. Effects of hepatitis E virus infection on interferon production
Wang M; Huang Y; He M; Peng WJ; Tian DY
World J Gastroenterol; 2018 May; 24(20):2173-2180. PubMed ID: 29853735
[TBL] [Abstract][Full Text] [Related]
16. Interferon-stimulated gene 15 and the protein ISGylation system.
Zhang D; Zhang DE
J Interferon Cytokine Res; 2011 Jan; 31(1):119-30. PubMed ID: 21190487
[TBL] [Abstract][Full Text] [Related]
17. UBP43 is a novel regulator of interferon signaling independent of its ISG15 isopeptidase activity.
Malakhova OA; Kim KI; Luo JK; Zou W; Kumar KG; Fuchs SY; Shuai K; Zhang DE
EMBO J; 2006 Jun; 25(11):2358-67. PubMed ID: 16710296
[TBL] [Abstract][Full Text] [Related]
18. HERC5 E3 ligase mediates ISGylation of hepatitis B virus X protein to promote viral replication.
Bawono RG; Abe T; Qu M; Kuroki D; Deng L; Matsui C; Ryo A; Suzuki T; Matsuura Y; Sugiyama M; Mizokami M; Shimotohno K; Shoji I
J Gen Virol; 2021 Oct; 102(10):. PubMed ID: 34661519
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of hepatitis C virus replication by IFN-mediated ISGylation of HCV-NS5A.
Kim MJ; Yoo JY
J Immunol; 2010 Oct; 185(7):4311-8. PubMed ID: 20810994
[TBL] [Abstract][Full Text] [Related]
20. USP18 and ISG15 coordinately impact on SKP2 and cell cycle progression.
Vuillier F; Li Z; Commere PH; Dynesen LT; Pellegrini S
Sci Rep; 2019 Mar; 9(1):4066. PubMed ID: 30858391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
